Dublin, Jan. 18, 2016 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/5rzpcl/the_global) has announced the addition of the "The Global Glucose Monitoring Market" report to their offering.
Diabetes is a leading cause of death and disability in the worldwide. It increases the risk for heart disease, end-stage renal disease, blindness, amputation, andcomplications of pregnancy and is ranked as the sixth leading cause of death. Disease prevalence is driving sales of monitoring equipment. The glucose monitoring device and diabetes management market is focused on utilizing advancements recently introduced to provide easier-to-use products and more accurate glucose monitoring.
The Global Glucose Monitoring Market provides market estimates and forecasts for this important test category. As part of its coverage, the report breaks out the revenues earned by the glucose monitoring industry into appropriate segments so that businesses can assess the right market opportunity for the area they compete in.
There are many issues facing this industry. Some issues are helping to propel the market; while other issues are retarding growth forward. Issues and trends driving the market for glucose monitoring devices and diabetes management include: New innovations, Reimbursement challenges, Recalls, Aging of the population, Increasing life expectancy, Healthcare spending trends, Advances in sensors, Health insurance portability, Cost cutting, Healthcare efficiency, Capacity challenges, Growing acceptance of mobile technologies and other factors. These are discussed at length in the report, as are their role in market growth.
Although there are many participants in the market, a handful of companies continue to make a significant impact on the glucose monitoring devices and diabetes management market.
A select few are discussed here, including:
- Abbott Laboratories
- AgaMatrix Arkray, Inc
- Bayer Diabetes Bionime Corporation
- DexCom, Inc.
- Echo Therapeutics
- Entra Health Systems LLC
- Fora Care Inc
- Genesis Health Technologies
- GlySure Limited
- Insulet
- Johnson & Johnson
- Medtronic
- Nipro Diagnostics, Inc
- Nova Diabetes Care, Inc.
- Oak Tree International Holdings, Inc
- Prodigy Diabetes Care, LLC
- Roche U.S. Diagnostics, Inc.
Key Topics Covered:
- Executive Summary
- Introduction
- Traditional Glucose Monitoring Devices And Diabetes Management Market
- Continuous Glucose Monitoring And Sensor Market
- Issues And Trends
- Global Glucose Monitoring Devices And Diabetes Management Market And Competitor Analysis
- Market Analysis By Region
- Corporate Profiles
For more information visit http://www.researchandmarkets.com/research/5rzpcl/the_global
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices, Glucose Testing, Diabetes Devices


Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles
FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase
SpaceX IPO: Retail Investors to Play Historic Role in Record-Breaking Public Offering
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
Bill Ackman Eyes New Fund to Bet Against Market Complacency
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts
Britain Courts Anthropic Amid US Defense Department Dispute
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts 



